Vycor Medical (VYCO) Net Equity Issued and Repurchased (2010 - 2017)

Vycor Medical (VYCO) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $666.0 in Q4 2017.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $666.0 in Q4 2017; TTM through Sep 2018 was $666.0, a 99.92% decrease from a year earlier, with the FY2017 full-year figure at $842873.0, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q4 2017 stood at $666.0, down from $842207.0 in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for VYCO reached as high as $4.1 million in Q1 2014 and fell as low as $666.0 in Q4 2017.
• Historically, Net Equity Issued and Repurchased has averaged $1.2 million across 3 years, with a median of $842207.0 in 2017.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 43.04% in 2013 and fell as far as 43.04% in 2013.
• Year by year, Net Equity Issued and Repurchased stood at $28481.0 in 2013, then jumped by 3164.84% to $929860.0 in 2014, then sank by 99.93% to $666.0 in 2017.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $666.0 in Q4 2017, $842207.0 in Q1 2017, and $929860.0 in Q2 2014.